Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B

BACKGROUND/AIMS: Long-term data on antiviral therapy in Korean patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) are limited. This study evaluated the efficacy and safety of entecavir (ETV) and lamivudine (LAM) over 240 weeks. METHODS: Treatment-naive patients with HBeAg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kwan Sik, Kweon, Young-Oh, Um, Soon-Ho, Kim, Byung-Ho, Lim, Young Suk, Paik, Seung Woon, Heo, Jeong, Lee, Heon-Ju, Kim, Dong Joon, Kim, Tae Hun, Lee, Young-Sok, Byun, Kwan Soo, Kim, Daeghon, Lee, Myung Seok, Yu, Kyungha, Suh, Dong Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760004/
https://www.ncbi.nlm.nih.gov/pubmed/28946736
http://dx.doi.org/10.3350/cmh.2016.0040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760004/
https://www.ncbi.nlm.nih.gov/pubmed/28946736
http://dx.doi.org/10.3350/cmh.2016.0040

Ejemplares similares